Published in Breast Cancer Res on January 01, 2008
Metastasis: new perspectives on an old problem. Mol Cancer (2011) 1.42
Short-Form Ron Promotes Spontaneous Breast Cancer Metastasis through Interaction with Phosphoinositide 3-Kinase. Genes Cancer (2011) 1.01
Caught in the act: revealing the metastatic process by live imaging. Dis Model Mech (2013) 0.99
Minimization of thermodynamic costs in cancer cell invasion. Proc Natl Acad Sci U S A (2013) 0.98
Embryonic morphogen nodal promotes breast cancer growth and progression. PLoS One (2012) 0.97
Meta-analysis of archived DNA microarrays identifies genes regulated by hypoxia and involved in a metastatic phenotype in cancer cells. BMC Cancer (2010) 0.93
Alcohol promotes breast cancer cell invasion by regulating the Nm23-ITGA5 pathway. J Exp Clin Cancer Res (2011) 0.93
The detection, treatment, and biology of epithelial ovarian cancer. J Ovarian Res (2010) 0.92
Prognostic and predictive biomarkers: tools in personalized oncology. Mol Diagn Ther (2014) 0.92
Prognostic significance of CD26 in patients with colorectal cancer. PLoS One (2014) 0.89
Inherited variation in miR-290 expression suppresses breast cancer progression by targeting the metastasis susceptibility gene Arid4b. Cancer Res (2013) 0.89
Secretomic analysis identifies alpha-1 antitrypsin (A1AT) as a required protein in cancer cell migration, invasion, and pericellular fibronectin assembly for facilitating lung colonization of lung adenocarcinoma cells. Mol Cell Proteomics (2012) 0.89
Disabled-2 downregulation promotes epithelial-to-mesenchymal transition. Br J Cancer (2010) 0.88
Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring. Cancer Metastasis Rev (2015) 0.88
The interaction between CD44 on tumour cells and hyaluronan under physiologic flow conditions: implications for metastasis formation. Histochem Cell Biol (2012) 0.86
Adhesion of small cell lung cancer cells to E- and P-selectin under physiological flow conditions: implications for metastasis formation. Histochem Cell Biol (2011) 0.86
TGF-β autocrine pathway and MAPK signaling promote cell invasiveness and in vivo mammary adenocarcinoma tumor progression. Oncol Rep (2012) 0.84
Activation of c-Met and upregulation of CD44 expression are associated with the metastatic phenotype in the colorectal cancer liver metastasis model. PLoS One (2014) 0.84
A low-dimensional deformation model for cancer cells in flow. Phys Fluids (1994) (2012) 0.83
Regulation of CXCR4-mediated invasion by DARPP-32 in gastric cancer cells. Mol Cancer Res (2012) 0.83
Preparation of bufalin-loaded pluronic polyetherimide nanoparticles, cellular uptake, distribution, and effect on colorectal cancer. Int J Nanomedicine (2014) 0.82
'Omic approaches to preventing or managing metastatic breast cancer. Breast Cancer Res (2011) 0.81
Loss of PCDH9 is associated with the differentiation of tumor cells and metastasis and predicts poor survival in gastric cancer. Clin Exp Metastasis (2015) 0.80
Network-based analysis identifies epigenetic biomarkers of esophageal squamous cell carcinoma progression. Bioinformatics (2014) 0.78
The Role of the PERK/eIF2α/ATF4/CHOP Signaling Pathway in Tumor Progression During Endoplasmic Reticulum Stress. Curr Mol Med (2016) 0.78
Pulmonary metastases after low-dose-rate brachytherapy for localized prostate cancer. Korean J Urol (2014) 0.77
Destructive impact of T-lymphocytes, NK and Mast cells on basal cell layers: implications for tumor invasion. BMC Cancer (2013) 0.77
Recombinant Lactococcus lactis NZ9000 secretes a bioactive kisspeptin that inhibits proliferation and migration of human colon carcinoma HT-29 cells. Microb Cell Fact (2016) 0.77
Perfluorooctanoic acid enhances colorectal cancer DLD-1 cells invasiveness through activating NF-κB mediated matrix metalloproteinase-2/-9 expression. Int J Clin Exp Pathol (2015) 0.76
Revisiting Seed and Soil: Examining the Primary Tumor and Cancer Cell Foraging in Metastasis. Mol Cancer Res (2017) 0.75
Recent insights into cigarette smoking as a lifestyle risk factor for breast cancer. Breast Cancer (Dove Med Press) (2017) 0.75
Inhibiting MDSC differentiation from bone marrow with phytochemical polyacetylenes drastically impairs tumor metastasis. Sci Rep (2016) 0.75
Cancer and Thrombosis: The Platelet Perspective. Front Cell Dev Biol (2017) 0.75
Identification of microRNA 885-5p as a novel regulator of tumor metastasis by targeting CPEB2 in colorectal cancer. Oncotarget (2017) 0.75
A Panel of Cancer Testis Antigens and Clinical Risk Factors to Predict Metastasis in Colorectal Cancer. J Biomark (2014) 0.75
Suppression of Akt1- β-catenin pathway in advanced prostate cancer promotes TGFβ1-mediated epithelial to mesenchymal transition and metastasis. Cancer Lett (2017) 0.75
Antitumoral effects of γCdcPLI, a PLA2 inhibitor from Crotalus durissus collilineatus via PI3K/Akt pathway on MDA-MB-231 breast cancer cell. Sci Rep (2017) 0.75
Distribution patterns of the metastases of the lung carcinoma in relation to histological type of the primary tumor: An autopsy study. Ann Thorac Med (2017) 0.75
Gene expression profiling predicts clinical outcome of breast cancer. Nature (2002) 71.36
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med (2004) 41.02
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet (2005) 29.45
The clonal evolution of tumor cell populations. Science (1976) 24.39
Genetics of gene expression surveyed in maize, mouse and man. Nature (2003) 22.17
A molecular signature of metastasis in primary solid tumors. Nat Genet (2002) 21.36
Genes that mediate breast cancer metastasis to lung. Nature (2005) 19.85
A multigenic program mediating breast cancer metastasis to bone. Cancer Cell (2003) 16.86
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature (2005) 15.57
Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer (2004) 14.55
The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev (1989) 13.15
Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol (1992) 12.96
Complex trait analysis of gene expression uncovers polygenic and pleiotropic networks that modulate nervous system function. Nat Genet (2005) 10.03
Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med (2001) 9.99
A progression puzzle. Nature (2002) 9.56
Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol (2004) 9.38
Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol (2003) 7.89
Uncovering regulatory pathways that affect hematopoietic stem cell function using 'genetical genomics'. Nat Genet (2005) 6.91
Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res (2007) 6.60
Metastasis results from preexisting variant cells within a malignant tumor. Science (1977) 6.47
Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest (2005) 6.10
From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci U S A (2003) 4.79
Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res (1977) 4.59
Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol (1998) 4.41
Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med (2000) 4.36
Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer (2003) 3.96
Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling. Cancer Res (2002) 3.95
Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1. Nat Genet (2005) 2.92
Myogenesis: fusion, myosin synthesis, and the mitotic cycle. Proc Natl Acad Sci U S A (1966) 2.64
Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res (1975) 2.49
Metastatic inefficiency. Adv Cancer Res (1990) 2.40
Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression. Int J Cancer (1998) 2.36
The seed and soil hypothesis: vascularisation and brain metastases. Lancet Oncol (2002) 2.27
Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation. Genes Chromosomes Cancer (1999) 2.19
Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site. J Urol (2003) 2.12
Multinucleated giant cells. Curr Opin Hematol (2000) 2.01
Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. Cancer Res (1984) 1.88
Tumour-cell fusion as a source of myeloid traits in cancer. Lancet Oncol (2005) 1.86
Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer. Breast Cancer Res (2006) 1.81
Clinical progression of breast cancer malignant behavior: what to expect and when to expect it. J Clin Oncol (2000) 1.78
Horizontal transfer of oncogenes by uptake of apoptotic bodies. Proc Natl Acad Sci U S A (2001) 1.76
Apoptosis: an early event in metastatic inefficiency. Cancer Res (2001) 1.74
Predicting a local recurrence after breast-conserving therapy by gene expression profiling. Breast Cancer Res (2006) 1.69
Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin. Cancer Res (2000) 1.55
Evidence for the clonal origin of spontaneous metastases. Science (1982) 1.52
A role for heterologous gap junctions between melanoma and endothelial cells in metastasis. J Clin Invest (2000) 1.45
CIRCULATING DNA AS A POSSIBLE FACTOR IN ONCOGENESIS. Science (1965) 1.44
Early cancer cell dissemination and late metastatic relapse: clinical reflections and biological approaches to the dormancy problem in patients. Semin Cancer Biol (2001) 1.44
Metastasis predictive signature profiles pre-exist in normal tissues. Clin Exp Metastasis (2006) 1.43
Metastases from testicular carcinoma. Study of 78 autopsied cases. Urology (1976) 1.41
Critical determinants of cancer metastasis: rationale for therapy. Cancer Chemother Pharmacol (1999) 1.35
Evidence that intravenously derived murine pulmonary melanoma metastases can originate from the expansion of a single tumor cell. Cancer Res (1986) 1.33
Spontaneous fusion in vivo between normal host and tumor cells: possible contribution to tumor progression and metastasis studied with a lectin-resistant mutant tumor. Mol Cell Biol (1983) 1.32
Donor Y chromosome in renal carcinoma cells of a female BMT recipient: visualization of putative BMT-tumor hybrids by FISH. Bone Marrow Transplant (2005) 1.27
Melanoma x macrophage hybrids with enhanced metastatic potential. Clin Exp Metastasis (1998) 1.23
Donor DNA in a renal cell carcinoma metastasis from a bone marrow transplant recipient. Bone Marrow Transplant (2004) 1.21
Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer. Oncogene (1996) 1.20
Macrophage fusion: are somatic and cancer cells possible partners? Trends Cell Biol (2005) 1.20
In vivo hybridisation of human tumour and normal hamster cells. Nature (1974) 1.20
Loss of intercellular junctional communication correlates with metastatic potential in mammary adenocarcinoma cells. Proc Natl Acad Sci U S A (1988) 1.17
Tumour cell hybridization and metastasis revisited. Melanoma Res (2000) 1.15
Osteoclast nuclei of myeloma patients show chromosome translocations specific for the myeloma cell clone: a new type of cancer-host partnership? J Pathol (2007) 1.12
Induction of the metastatic phenotype in a mouse tumor model by 5-azacytidine, and characterization of an antigen associated with metastatic activity. Proc Natl Acad Sci U S A (1984) 1.10
Lethal deformation of cancer cells in the microcirculation: a potential rate regulator of hematogenous metastasis. Int J Cancer (1992) 1.06
Changes in the tumorigenic and metastatic properties of tumor cells treated with quercetin or 5-azacytidine. Int J Cancer (1987) 1.04
Dynamic heterogeneity: rapid generation of metastatic variants in mouse B16 melanoma cells. Science (1984) 1.01
Metastatic variants are generated spontaneously at a high rate in mouse KHT tumor. Proc Natl Acad Sci U S A (1982) 0.99
Identify metastasis-associated genes in hepatocellular carcinoma through clonality delineation for multinodular tumor. Cancer Res (2002) 0.98
Circulating nucleic acids in plasma and serum (CNAPS) and its relation to stem cells and cancer metastasis: state of the issue. Histol Histopathol (2004) 0.96
Use of NeoR B16F1 murine melanoma cells to assess clonality of experimental metastases in the immune-deficient chick embryo. Clin Exp Metastasis (1988) 0.96
Production of a more aggressive tumor cell variant by spontaneous fusion of two mouse tumor subpopulations. Cancer Res (1989) 0.90
Co-opting macrophage traits in cancer progression: a consequence of tumor cell fusion? Contrib Microbiol (2006) 0.87
Molecular clonality of in-transit melanoma metastasis. Am J Pathol (2001) 0.86
Possible epigenetic mechanisms of tumor progression: induction of high-frequency heritable but phenotypically unstable changes in the tumorigenic and metastatic properties of tumor cell populations by 5-azacytidine treatment. J Cell Physiol Suppl (1984) 0.85
Spontaneously formed tumorigenic hybrids of Meth A sarcoma cells and macrophages in vivo. Int J Cancer (2003) 0.85
Functionality of circulating DNA: the hypothesis of genometastasis. Ann N Y Acad Sci (2001) 0.84
Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines. Jpn J Cancer Res (2001) 0.83
Generation of invasive and metastatic variants of a non-metastatic T-cell lymphoma by in vivo fusion with normal host cells. Int J Cancer (1984) 0.83
Growth and histopathology of melanotic and amelanotic derivatives of the Cloudman melanoma S91. J Natl Cancer Inst (1952) 0.82
Somatic cell hybridization in vivo and in vitro in relation to the metastatic phenotype. Biochim Biophys Acta (1985) 0.82
Is cancer a macrophage-mediated autoaggressive disease? Lancet (1987) 0.82
Role of tight junctions in the occurrence of cancer invasion and metastasis. Med Electron Microsc (1999) 0.81
Rapid phenotype variation in cells derived from lung metastases of KHT fibrosarcoma. Invasion Metastasis (1984) 0.78
Comparative morphology of primary and secondary deposits of prostatic adenocarcinoma. Cancer (1981) 0.77
Karyological properties of human-mouse somatic hybrids. Proc Natl Acad Sci U S A (1971) 0.77
In vivo tumour x host cell fusion in spontaneous Syrian hamster metastasis. Eur J Cancer Clin Oncol (1989) 0.76
5-azacytidine induces micronuclei in and morphological transformation of Syrian hamster embryo fibroblasts in the absence of unscheduled DNA synthesis. Mutat Res (1992) 0.76
Clonal analysis of the malignant properties of B16 melanoma cells treated with the DNA hypomethylating agent 5-azacytidine. Clin Exp Metastasis (1988) 0.76
Bromodomain 4 activation predicts breast cancer survival. Proc Natl Acad Sci U S A (2008) 2.15
The future of mouse QTL mapping to diagnose disease in mice in the age of whole-genome association studies. Annu Rev Genet (2008) 1.46
Deletion of the proline-rich region of the murine metastasis susceptibility gene Brd4 promotes epithelial-to-mesenchymal transition- and stem cell-like conversion. Cancer Res (2011) 1.16
Differential microRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer. Hum Mutat (2012) 1.07
The origins of breast cancer prognostic gene expression profiles. Cancer Res (2009) 1.02
WISP1/CCN4: a potential target for inhibiting prostate cancer growth and spread to bone. PLoS One (2013) 0.95
Molecular profiling of ulcerative colitis-associated neoplastic progression. Exp Mol Pathol (2005) 0.93
Gene expression profiles and breast cancer metastasis: a genetic perspective. Clin Exp Metastasis (2009) 0.89
BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane. PLoS One (2013) 0.88
Characterization of N-acetyltransferase 1 and 2 polymorphisms and haplotype analysis for inflammatory bowel disease and sporadic colorectal carcinoma. BMC Med Genet (2007) 0.85
Germline genetic variation modulates tumor progression and metastasis in a mouse model of neuroendocrine prostate carcinoma. PLoS One (2013) 0.83
Association of ulcerative colitis with the inflammatory bowel disease susceptibility locus IBD2 in non-Jewish Caucasians and evidence of genetic heterogeneity among racial and ethnic populations with Crohn disease. Am J Med Genet (2002) 0.78
Inherited metastasis susceptibility and the implications for clinical prognosis. Discov Med (2005) 0.75